LawParents Sue OpenAI, Alleging ChatGPT Helped Daughter Stop Epilepsy DrugBy Helena WardOct 28, 2026, 11:20 PM UTC
BusinessThe Epilepsy Foundation Launches a New Research Study to Find Biomarkers for Treatment of Focal Seizures in People with EpilepsyBy Nasdaq OMXApr 24, 2018, 12:06 PM UTC
BusinessMariMed Introduces Licensed Nature’s Heritage Cannabis® Brand in MarylandBy Nasdaq OMXApr 24, 2018, 12:02 PM UTC
BusinessBoston Marathon Athlete Attempting to Break the Guinness World Record for the Fastest Marathon Ever Run Backwards Finishes Race in 5 Hours, 43 Minutes, 59 SecondsBy Nasdaq OMXApr 16, 2018, 9:04 PM UTC
BusinessAdamas Announces Multiple Data Presentations at the American Academy of Neurology Annual MeetingBy Nasdaq OMXApr 12, 2018, 9:09 PM UTC
BusinessZynerba Pharmaceuticals Initiates Open-Label Phase 2 Trial of ZYN002 in Developmental and Epileptic Encephalopathies (DEE)By Nasdaq OMXApr 10, 2018, 11:01 AM UTC
BusinessEpilepsy Foundation Awards $200,000 at ‘Shark Tank’ Competition for Innovative Products that Aim to Improve Epilepsy Treatment and CareBy Nasdaq OMXMar 5, 2018, 1:01 PM UTC
